BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 27465657)

  • 1. Social Network, Surgeon, and Media Influence on the Decision to Undergo Contralateral Prophylactic Mastectomy.
    Venetis MK; MacGeorge EL; Baptiste DF; Mouton A; Friley LB; Pastor R; Hatten K; Lagoo J; Bowling MW; Clare SE
    Am J Clin Oncol; 2018 Jun; 41(6):519-525. PubMed ID: 27465657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient Reactions to Surgeon Recommendations About Contralateral Prophylactic Mastectomy for Treatment of Breast Cancer.
    Katz SJ; Janz NK; Abrahamse P; Wallner LP; Hawley ST; An LC; Ward KC; Hamilton AS; Morrow M; Jagsi R
    JAMA Surg; 2017 Jul; 152(7):658-664. PubMed ID: 28384687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Active Participation in Decision-Making in Contralateral Prophylactic Mastectomy for Patients With Breast Cancer.
    Huang J; Chagpar A
    J Surg Res; 2019 Oct; 242():129-135. PubMed ID: 31075657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contralateral Prophylactic Mastectomy Decisions in a Population-Based Sample of Patients With Early-Stage Breast Cancer.
    Jagsi R; Hawley ST; Griffith KA; Janz NK; Kurian AW; Ward KC; Hamilton AS; Morrow M; Katz SJ
    JAMA Surg; 2017 Mar; 152(3):274-282. PubMed ID: 28002555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgeon Influence on Variation in Receipt of Contralateral Prophylactic Mastectomy for Women With Breast Cancer.
    Katz SJ; Hawley ST; Hamilton AS; Ward KC; Morrow M; Jagsi R; Hofer TP
    JAMA Surg; 2018 Jan; 153(1):29-36. PubMed ID: 28903158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "It felt like unfinished business, it feels like that's finished now": Women's experiences of decision making around contralateral prophylactic mastectomy (CPM).
    Tollow P; Williams VS; Harcourt D; Paraskeva N
    Psychooncology; 2019 Jun; 28(6):1328-1334. PubMed ID: 30963646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of decision-making resources on satisfaction with decision to undergo contralateral prophylactic mastectomy (CPM).
    Huang J; Chagpar A
    Am J Surg; 2020 Jun; 219(6):1036-1038. PubMed ID: 31570198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An exploration of Australian psychologists' role in assessing women considering risk-reducing or contralateral prophylactic mastectomy.
    Braude L; Laidsaar-Powell R; Gilchrist J; Kirsten L; Juraskova I
    Breast; 2017 Apr; 32():105-111. PubMed ID: 28135658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association between patient attitudes and values and the strength of consideration for contralateral prophylactic mastectomy in a population-based sample of breast cancer patients.
    Hawley ST; Griffith KA; Hamilton AS; Ward KC; Morrow M; Janz NK; Katz SJ; Jagsi R
    Cancer; 2017 Dec; 123(23):4547-4555. PubMed ID: 28810062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective Study of Surgical Decision-making Processes for Contralateral Prophylactic Mastectomy in Women With Breast Cancer.
    Parker PA; Peterson SK; Bedrosian I; Crosby MA; Shen Y; Black DM; Babiera G; Kuerer HM; Ying J; Dong W; Cantor SB; Brewster AM
    Ann Surg; 2016 Jan; 263(1):178-83. PubMed ID: 25822675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Practitioner Opinion on Contralateral Prophylactic Mastectomy: How Do We Steer a Patient-Driven Discussion?
    Schellenberg AE; Stypulkowski A; Cordeiro E; Holloway CMB; Eisen A; Scheer AS
    Ann Surg Oncol; 2019 Oct; 26(11):3489-3494. PubMed ID: 31187367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychosocial factors associated with the uptake of contralateral prophylactic mastectomy among BRCA1/2 mutation noncarriers with newly diagnosed breast cancer.
    Hamilton JG; Genoff MC; Salerno M; Amoroso K; Boyar SR; Sheehan M; Fleischut MH; Siegel B; Arnold AG; Salo-Mullen EE; Hay JL; Offit K; Robson ME
    Breast Cancer Res Treat; 2017 Apr; 162(2):297-306. PubMed ID: 28150129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient decision aid for contralateral prophylactic mastectomy for use in the consultation: a feasibility study.
    Squires JE; Stacey D; Coughlin M; Greenough M; Roberts A; Dorrance K; Clemons M; Caudrelier JM; Graham ID; Zhang J; Varin MD; Arnaout A
    Curr Oncol; 2019 Apr; 26(2):137-148. PubMed ID: 31043816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Women's preferences for contralateral prophylactic mastectomy following unilateral breast cancer: What risk-reduction makes it worthwhile?
    Tesson S; Richards I; Porter D; Phillips KA; Rankin N; Costa D; Musiello T; Marven M; Butow P
    Breast; 2017 Feb; 31():233-240. PubMed ID: 27969575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-Term Satisfaction and Body Image After Contralateral Prophylactic Mastectomy.
    Anderson C; Islam JY; Elizabeth Hodgson M; Sabatino SA; Rodriguez JL; Lee CN; Sandler DP; Nichols HB
    Ann Surg Oncol; 2017 Jun; 24(6):1499-1506. PubMed ID: 28058563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The development of a template for psychological assessment of women considering risk-reducing or contralateral prophylactic mastectomy: A national Delphi consensus study.
    Braude L; Kirsten L; Gilchrist J; Juraskova I
    Psychooncology; 2018 Oct; 27(10):2349-2356. PubMed ID: 29966172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting women's intentions for contralateral prophylactic mastectomy: An application of an extended theory of planned behaviour.
    Richards I; Tesson S; Porter D; Phillips KA; Rankin N; Musiello T; Marven M; Butow P
    Eur J Oncol Nurs; 2016 Apr; 21():57-65. PubMed ID: 26952679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Motivations for contralateral prophylactic mastectomy as a function of socioeconomic status.
    Baptiste DF; MacGeorge EL; Venetis MK; Mouton A; Friley LB; Pastor R; Hatten K; Lagoo J; Clare SE; Bowling MW
    BMC Womens Health; 2017 Feb; 17(1):10. PubMed ID: 28143474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and pilot testing of a Decision Aid (DA) for women with early-stage breast cancer considering contralateral prophylactic mastectomy.
    Ager B; Jansen J; Porter D; Phillips KA; Glassey R; ; Butow P
    Breast; 2018 Aug; 40():156-164. PubMed ID: 29857282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in physician opinions about controversial issues surrounding contralateral prophylactic mastectomy (CPM): A survey of physicians from accredited breast centers in the United States.
    Yao K; Bleicher R; Moran M; Chang C; Dietz J; Stearns V; Connolly J; Sarantou T; Kurtzman S;
    Cancer Med; 2020 May; 9(9):3088-3096. PubMed ID: 32159280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.